Tempus AI EPS - Earnings per Share 2023-2025 | TEM
- Tempus AI EPS for the quarter ending March 31, 2025 was $-0.40, a 72.79% decline year-over-year.
- Tempus AI EPS for the twelve months ending March 31, 2025 was $-5.16, a 11.45% increase year-over-year.
- Tempus AI 2024 annual EPS was $-6.23, a 48.33% increase from 2023.
- Tempus AI 2023 annual EPS was $-4.2, a 20.75% decline from 2022.
- Tempus AI 2022 annual EPS was $-5.3, a 0% decline from .
Tempus AI Annual EPS | |
---|---|
2024 | $-6.23 |
2023 | $-4.20 |
2022 | $-5.30 |
Tempus AI Quarterly EPS | |
---|---|
2025-03-31 | $-0.40 |
2024-12-31 | $2.56 |
2024-09-30 | $-0.46 |
2024-06-30 | $-6.86 |
2024-03-31 | $-1.47 |
2023-12-31 | $-1.06 |
2023-09-30 | $-1.03 |
2023-06-30 | $-1.07 |
2023-03-31 | $-1.04 |
2022-12-31 | $0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $10.745B | $0.693B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.427B | 59.33 |
Hims & Hers Health (HIMS) | United States | $12.608B | 131.00 |
IRhythm Technologies (IRTC) | United States | $4.683B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.012B | 62.68 |
Hinge Health (HNGE) | United States | $3.034B | 0.00 |
Privia Health (PRVA) | United States | $2.827B | 193.25 |
Enovis (ENOV) | United States | $1.816B | 10.12 |
Schrodinger (SDGR) | United States | $1.807B | 0.00 |
Phreesia (PHR) | United States | $1.595B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.555B | 0.00 |
Omnicell (OMCL) | United States | $1.452B | 25.62 |
Azenta (AZTA) | United States | $1.316B | 61.17 |
10x Genomics (TXG) | United States | $1.160B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
Claritev (CTEV) | United States | $0.650B | 0.00 |
Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.550B | 164.50 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.403B | 0.00 |
Outset Medical (OM) | United States | $0.371B | 0.00 |
TruBridge (TBRG) | United States | $0.358B | 794.00 |
Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.142B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
Pulmonx (LUNG) | United States | $0.128B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
CareCloud (CCLD) | United States | $0.092B | 3.52 |
111 (YI) | China | $0.073B | 0.00 |
HeartBeam (BEAT) | United States | $0.056B | 0.00 |
P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Zhongchao (ZCMD) | China | $0.027B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |